TY - JOUR
T1 - Familial chronic megacolon presenting in childhood or adulthood
T2 - Seeking the presumed gene association
AU - Camilleri, Michael
AU - Wieben, Eric
AU - Eckert, Deborah
AU - Carlson, Paula
AU - Hurley O’Dwyer, Ralph
AU - Gibbons, Denys
AU - Acosta, Andres
AU - Klee, Eric W.
N1 - Funding Information:
Funding information Dr Camilleri is supported by grants R01-DK115950 and R01-DK67071 from National Institutes of Health. This study was supported by a research award from the Center for Individualized Medicine at Mayo Clinic. We thank the members of the family studied for providing medical information and biological samples. We are grateful to Drs. Sara Eleoff Van Durme and Jane Benson at Johns Hopkins Bayview Medical Center for sharing radiological studies and interpretation of the colon X-ray of one of the pediatric cases. We thank Mrs. Cindy Stanislav for excellent secretarial assistance.
Funding Information:
Dr Camilleri is supported by grants R01‐DK115950 and R01‐DK67071 from National Institutes of Health. This study was supported by a research award from the Center for Individualized Medicine at Mayo Clinic.
Publisher Copyright:
© 2019 John Wiley & Sons Ltd
PY - 2019/4
Y1 - 2019/4
N2 - Objective: We identified a pedigree over five generations with 49 members, some of whom had chronic megacolon presenting in adolescence or adulthood. We aimed to assess the genetic cause of chronic megacolon through clinical and DNA studies. Design: After ethical approval and informed consent, family members provided answers to standard bowel disease questionnaires, radiological or surgical records, and DNA (buccal mucosal scraping). Exome DNA sequencing of colon tissue or blood DNA from seven family members with colon or duodenal dilatation, or no megacolon (n = 1) was carried out. Sanger sequencing was performed in 22 additional family members to further evaluate candidate variants. The study focused on genes of potential relevance to enteric nerve (ENS) maturation and Hirschsprung's disease or megacolon, based on the literature (GFRA1, NKX2-1, KIF26A, TPM3, ACTG2, SCN10A, and C17orf107 [CHRNE]) and other genetic variants that co-segregated with megacolon in the six affected family members. Results: Information was available in all except five members alive at time of study; among 30 members who provided DNA, six had definite megacolon, one megaduodenum, seven significant constipation without bowel dilatation, and 16 normal bowel function by questionnaire. Among genes studied, SEMA3F (g.3:50225360A>G; c1873A>G) was found in 6/6 family members with megacolon. The SEMA3F gene variant was assessed as potentially pathogenic, based on M-CAP in silico prediction. SEMA3F function is associated with genes (KIT and PDGFRB) that impact intestinal pacemaker function. Conclusion: Familial chronic megacolon appears to be associated with SEMA3F, which is associated with genes impacting enteric nerve or pacemaker function.
AB - Objective: We identified a pedigree over five generations with 49 members, some of whom had chronic megacolon presenting in adolescence or adulthood. We aimed to assess the genetic cause of chronic megacolon through clinical and DNA studies. Design: After ethical approval and informed consent, family members provided answers to standard bowel disease questionnaires, radiological or surgical records, and DNA (buccal mucosal scraping). Exome DNA sequencing of colon tissue or blood DNA from seven family members with colon or duodenal dilatation, or no megacolon (n = 1) was carried out. Sanger sequencing was performed in 22 additional family members to further evaluate candidate variants. The study focused on genes of potential relevance to enteric nerve (ENS) maturation and Hirschsprung's disease or megacolon, based on the literature (GFRA1, NKX2-1, KIF26A, TPM3, ACTG2, SCN10A, and C17orf107 [CHRNE]) and other genetic variants that co-segregated with megacolon in the six affected family members. Results: Information was available in all except five members alive at time of study; among 30 members who provided DNA, six had definite megacolon, one megaduodenum, seven significant constipation without bowel dilatation, and 16 normal bowel function by questionnaire. Among genes studied, SEMA3F (g.3:50225360A>G; c1873A>G) was found in 6/6 family members with megacolon. The SEMA3F gene variant was assessed as potentially pathogenic, based on M-CAP in silico prediction. SEMA3F function is associated with genes (KIT and PDGFRB) that impact intestinal pacemaker function. Conclusion: Familial chronic megacolon appears to be associated with SEMA3F, which is associated with genes impacting enteric nerve or pacemaker function.
KW - SEMA3F
KW - congenital
KW - pseudo-obstruction
UR - http://www.scopus.com/inward/record.url?scp=85060348184&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060348184&partnerID=8YFLogxK
U2 - 10.1111/nmo.13550
DO - 10.1111/nmo.13550
M3 - Article
C2 - 30663199
AN - SCOPUS:85060348184
SN - 1350-1925
VL - 31
JO - Neurogastroenterology and Motility
JF - Neurogastroenterology and Motility
IS - 4
M1 - e13550
ER -